Genetic predisposition to prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 2, Issue 1, 1999, Pages 9-15

  Eeles, R A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Familial; Genetics; Prostate cancer; UK study

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 1; FAMILIAL DISEASE; GENE LOCUS; GENETIC MODEL; GENETIC PREDISPOSITION; GENETIC RISK; GENETICS; HIGH RISK POPULATION; HUMAN; MULTIGENE FAMILY; PENETRANCE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032974501     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500279     Document Type: Article

References (71)

1. Office for National Statistics series SB1.NO24. Cancer statistics registrations. England and Wales 1991. Her Majesty's Stationery Office: London, 1991.
2. Office for National Statistics series DH2.NO23. Mortality statistics by cause. England and Wales 1996. Her Majesty's Stationery Office: London, 1998.
3. Von Eschenbach A et al. American Cancer Society guidelines for the early detection of prostate cancer. Cancer 1997; 80: 1805-1807.
4. Coleman MP et al. Trends in Cancer Incidence and Mortality. IARC: Lyon, France, 1993, Ch. 22, pp 21.
5. Eeles RA, Cannon-Albright LA. Familial prostate cancer and its management. In: Eeles RA, Ponder BAJ, Easton DF, Horwich A (eds). Genetic Predisposition to Cancer. Chapman & Hall: London, 1996, pp 320-332.
6. Morganti G et al. Recherches clinico-statistiques et génétiques sur les néopasies de la prostate. Acta Genetica Statistica 1959; 6: 304-305.
7. Krain LS. Some epidemiologic variables in prostatic carcinoma in California. Prev Med 1974; 3: 154-159.
8. Fincham SM, Hill GB, Hanson J, Wijayasinghe C. Epidemiology of prostate cancer: a case control study. Prostate 1990; 17: 189-206.
9. Cannon LA et al. Genetic epidemiology of prostate cancer in the Utah Mormon Genealogy. Cancer Surv 1982; 1: 47-69.
10. Meikle AW, Smith JA, West DW. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. Prostate 1985; 6: 121-128.
11. Isaacs SD et al. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995; 87: 991-996.
12. Keetch DW, Rice JP, Suarez BK, Catalona WJ. Familial aspects of prostate cancer: a case control study. J Urol 1995; 154: 2100-2102.
13. Steele R, Lees REM, Kraus AS, Rao C. Sexual factors in the epidemiology of cancer of the prostate. J Chron Dis 1971; 24: 29-37.
14. Schuman T et al. Epidemiologic study of prostatic cancer: preliminary report. Cancer Treatment Reports 1977; 61: 181-186.
15. Steinberg GD et al. Family history and the risk of prostate cancer. Prostate 1990; 17: 337-347.
16. Spitz MR et al. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991; 146: 1305-1307.
17. Ghadirian P, Cadotte M, Lacroix A, Perret C. Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate 1991; 19: 43-52.
18. Ghadirian P, Howe GR, Hislop TG, Maisonneuve P. Family history of prostate cancer: a multi-centre case-control study in Canada. Int J Cancer 1997; 70: 679-681.
19. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600-1608.
20. Grönberg H, Damber L, Damber JE. Familial prostate cancer in Sweden. Cancer 1996; 77: 138-143.
21. Carter BS et al. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367-3371.
22. Grönberg H, Damber L, Damber JE, Iselius L. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Amer J Epidemiol 1997; 146: 552-557.
23. Knudson AG. Hereditary cancer, oncogenes and antioncogenes. Cancer Res 1985; 45: 1437-1443.
24. Mulligan LM et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460.
25. Narod S et al. The impact of family history on early detection of prostate cancer. Nat Med 1995; 1: 99-101.
26. Monroe KR et al. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1995; 1: 827-832.
27. Thiessen E. Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer 1974; 34: 1102-1107.
28. Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H. Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer. Br J Med 1992; 305: 855-857.
29. Macklin MT. The genetic basis of human mammary cancer. Proceedings of the Second National Cancer Conference. New York: American Cancer Society, 1954, pp 1074-1087.
30. Anderson DE, Badzioch MD. Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 1992; 84: 1114-1117.
31. Sellars TA et al. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst 1994; 86: 1860-1865.
32. Ford D et al. Risks of cancer in BRCAI-mutation carriers. Lancet 1994; 343: 692-695.
33. Carter BS et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993; 150: 797-802.
34. Zahm SH et al. A case-control study of soft tissue sarcoma. Am J Epidemiol 1989; 130: 665-674.
35. Smith JR et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996; 274: 1371-1374.
36. Cooney KA et al. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst 1997; 89: 955-959.
37. Hsieh C-L et al. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst 1997; 89: 1893-1894.
38. McIndoe RA et al. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet 1997; 61: 347-353.
39. Eeles RA et al. Linkage analysis of chromosome 1q markers in 136 prostate cancer families. Am J Hum Genet 1998; 62: 653-658.
40. Berthon P et al. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998; 62: 1416-1424.
41. Grönberg H et al. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res 1997; 57: 4707-4709.
42. Grönberg et al. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA 1997; 278: 1251-1255.
43. Keetch DW et al. Clinical and pathological features of hereditary prostate cancer. J Urol 1996; 155: 1841-1843.
44. Bastacky et al. Pathological features of hereditary prostate cancer. J Urol 1995; 153: 987-992.
45. Cannon-Albright LA, Eeles RA. Progress in prostate cancer. Nat Genet 1995; 9: 336-337.
46. Thorlacius S et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996; 13: 117-119.
47. Navone NM et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 1993; 85: 1657-1669.
48. Bookstein R et al. Promoter deletion and loss of retinoblastoma gene expression in human prostate cancer. Proc Natl Acnd Sci USA 1990; 87: 7762-7766.
49. Dunsmuir WD et al. Prostate cancer and the contribution of the breast cancer susceptibility gene (BRCA2). Br J Urol 1997; 79 (Suppl 4, abstract 21): 6.
50. Eagle LR et al. Mutation at the MXI1 gene in prostate cancer. Nat Genet 1995; 9: 249-255.
51. Dong J-T et al. KA11, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995; 268: 884-886.
52. Edwards SM et al. No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. Br J Cancer 1997; 76: 992-1000.
53. Carter BS et al. Allelic loss of chromosomes 16qand 10q in human prostate cancer. Proc Natl Acad Sci USA 1990; 87: 8751-8755.
54. Bova GS et al. Homozygous deletion and frequent allele loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 1993; 53: 3869-3873.
55. Bergerheim USR, Kunimi K, Collins VP, Ekman P. Deletion mapping of chromosomes 8, 10 and 16 in human prostate carcinoma. Gene Chromosom Cancer 1991; 3: 215-220.
56. Cannon-Albright LA et al. Test of candidate loci for a prostate cancer susceptibility locus in a set of high risk kindreds. Am Society of Human Genetics 1994; 55: A147, 847.
57. Latil A et al. Genetic alterations in localised prostate cancer: identification of a common region of deletion on chromosome arm 18q. Gene Chromosom Cancer 1994; 11: 119-125.
58. Gao X et al. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995; 55: 1002-1005.
59. Hollstein MC, Sidransky D, Voglestein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
60. Dobashi Y et al. DNA polymerase β gene mutation in human prostate cancer. Cancer Res 1994; 54: 2827-2829.
61. Ichikawa T et al. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res 1994; 54: 2299-2302.
62. Ichikawa T et al. Localisation of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 1992; 52: 3486-3490.
63. Berube NG, Speevak MD, Chevrette M. Suppression of tumorigenicity of human prostate cancer cells by introduction of human chromosome del (12) (q13). Cancer Res 1994; 54: 3077-3081.
64. Sleddens HFBM et al. Trinucleotide repeat polymorphism in the androgen receptor gene. Hum Mol Genet 1993; 2: 273.
65. Coetzee GA, Ross RK. Prostate cancer and the androgen receptor. J Natl Cancer Res 1994; 86: 872-873.
66. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995; 55: 1937-1940.
67. Hardy DO et al. Androgen receptor CAG repent lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 1996; 81: 4400-4405.
68. Giovannucci E et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997; 94: 3320-3323.
69. Ingles SA et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997; 89: 166-170.
70. Stanford JL et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997; 57: 1194-1198.
71. Xu J et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998; 20: 175-179.